Detection of Metastases in Patients with Cutaneous Melanoma Using FDG-PET/CT
Authors:
- 1 July 2007
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 35 (4) , 547-553
Abstract
This study aimed to detect metastases in patients with stage III or IV cutaneous melanoma by 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT). Thirty-nine patients with clinically evident stage III or IV melanoma underwent whole-body FDG-PET/CT scans for metastatic disease and these results were compared with those of biopsy. Scans for 38 of the patients were evaluated; one patient's scan could not be evaluated. There were 11 true-positive, two false-positive, 24 true-negative and one false-negative scans for the detection of melanoma metastases, with sensitivity 91%, specificity 92%, accuracy 92%, and positive and negative predictive values 84% and 96%, respectively. False-positive FDG-PET/CT scans were due to sarcoidosis in the lung and infected cyst in the liver. It is concluded that FDG-PET/CT scanning has high sensitivity and specificity for detecting stage III or IV metastatic melanoma.Keywords
This publication has 29 references indexed in Scilit:
- Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive PatientsJournal of Clinical Oncology, 2006
- Imaging of metastatic melanomaCancer Imaging, 2006
- Whole body PET/CT for initial staging of choroidal melanomaBritish Journal of Ophthalmology, 2005
- Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanomaSurvey of Ophthalmology, 2004
- The natural course of cutaneous melanomaJournal of Surgical Oncology, 2004
- The Role of Fluorine-18 Deoxyglucose Positron Emission Tomography in the Management of Patients With Metastatic Melanoma: Impact on Surgical Decision MakingClinical Nuclear Medicine, 2003
- Positron emission tomography for staging and management of malignant melanomaBritish Journal of Surgery, 2002
- Concurrent Induction of Lymphangiogenesis, Angiogenesis, and Macrophage Recruitment by Vascular Endothelial Growth Factor-C in MelanomaThe American Journal of Pathology, 2001
- FDG-PET screening for cerebral metastases in patients with suspected malignancyNuclear Medicine Communications, 1996
- The Orderly Progression of Melanoma Nodal MetastasesAnnals of Surgery, 1994